Showing results (221-230 of 250) with videos related to
Sort By:
Pageof 25
Transplantation|October 1, 1988
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejectionD J Norman, C F Shield, K R Henell, et al.Kidney International|March 1, 1994
Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin AE A Burdmann, T F Andoh, S Rosen, et al.Journal of the American Society of Nephrology : JASN|January 1, 1992
Cyst decompression surgery for autosomal dominant polycystic kidney diseaseL W Elzinga, J M Barry, V E Torres, et al.Research Communications in Chemical Pathology and Pharmacology|June 1, 1980
Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity in ratsW C Elliott, R A Parker, D C Houghton, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 1, 1994
A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantationD J Norman, J A Kimball, W M Bennett, et al.Journal of Cardiovascular Risk|September 29, 1999
Factors in cardiac risk stratification of candidates for renal transplantM S Lewis, R A Wilson, K Walker, et al.Kidney International|April 14, 1999
Effects of FK506 in rat and human resistance arteriesJ J De Lima, H Xue, L Coburn, et al.Kidney International|April 1, 1996
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathyF S Shihab, T F Andoh, A M Tanner, et al.Kidney International|August 1, 1995
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathyB A Young, E A Burdmann, R J Johnson, et al.Kidney International|November 11, 1992
On the probability that kidneys are different in autosomal dominant polycystic diseaseK D Gardner, J S Burnside, B J Skipper, et al.Pageof 25